![Stuart McLachlan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stuart McLachlan
Corporate Officer/Principal at Lypanosys Pte Ltd.
Stuart McLachlan active positions
Companies | Position | Start | End |
---|---|---|---|
Lypanosys Pte Ltd.
![]() Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Corporate Officer/Principal | 2011-06-05 | - |
Career history of Stuart McLachlan
Training of Stuart McLachlan
University of California, Davis | Doctorate Degree |
Statistics
International
United States | 2 |
Singapore | 2 |
Operational
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Consumer Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Lypanosys Pte Ltd.
![]() Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Health Technology |
- Stock Market
- Insiders
- Stuart McLachlan
- Experience